Heparin Solution Recalled Due to Sterility Assurance Failure
Central Admixture Pharmacy Services is recalling 2,992 bags of heparin solution nationwide due to failure of sterility assurance discovered during FDA inspection.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall with a risk-of-harm product (injectable sterile solution) where potential contamination from sterility failure could cause serious infection. No illnesses or injuries have been reported.
Plain-English summary
Central Admixture Pharmacy Services, Inc. is recalling 2,992 bags of heparin added to 0.9% sodium chloride injection (2,500 units/500 mL per bag) distributed nationwide. The affected lot numbers are: 37-888833 (expires 05/02/2023), 37-890537 (expires 05/09/2023), 37-892161 and 37-892163 (expire 05/16/2023), 37-893979 and 37-893992 (expire 05/23/2023), and 37-895755 and 37-895758 (expire 05/30/2023).
The manufacturer initiated the recall after an FDA inspection raised questions about whether these sterile products maintained their sterility. Lack of assurance of sterility in an injectable medication represents a significant quality and safety concern, as contamination could potentially cause serious infection.
The recalled product
- Product
- heparin added to 0.9% sodium chloride, 2,500 units/500 mL* (5 units/mL), 500 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA 18106, NDC 71285-8100-1.
- Manufacturer
- Central Admixture Pharmacy Services, Inc.
- Category
- Drug — Sterile Injectable
- Hazard
- sterility-failure
- contamination
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (13)
- Lot # 37-888833
- Exp 05/02/2023
- 37-890537
- Exp 05/09/2023
- 37-892161
- 37-892163
- Exp 05/16/2023
- 37-893979
- 37-893992
- Exp 05/23/2023
- 37-895755
- 37-895758
- Exp 05/30/2023
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27